Literature DB >> 43342

Failure of pyridoxine to effect neuroleptic-induced hyperprolactinemia in psychotic patients.

F Brambilla, G Penati, S Freni, S Bottinelli, C Maffei, V Maiella.   

Abstract

The effects of acute and repeated administration of pyridoxine on serum prolactin levels were studied in 18 chronic schizophrenics, 10 women and 8 men, in whom hyperprolactinemia had been induced by long-term treatment with phenothiazines, haloperidol, sulpiride or clopentixol. The patients were divided into 5 groups: group 1 received 300 mg of the vitamin per os in a single dose; group 2 received 300 mg of the vitamin per os for 7 days; group 3 received 300 mg of the vitamin iv as a single bolus; group 4 received 600 mg of the vitamin iv as a single bolus; group 5 received 1200 mg of the vitamin per os in a single dose. Prolactin levels were examined before and 15, 30, 60, 90, 120 and 150 min after the single administration of pyridoxine, either iv or per os, and on days 3,5, 7 of the chronic administration. There was no decrease in prolactin levels either after oral or iv administration of the drug, given in single or repeated doses. Therefore, this treatment is not useful for the suppression of hyperprolactinemia induced by neuroleptics.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43342     DOI: 10.1007/bf03350421

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Suppression of lactation with high doses of pyridoxine.

Authors:  R G Marcus
Journal:  S Afr Med J       Date:  1975-12-06

2.  Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).

Authors:  E N McIntosh
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

Review 3.  Studies on prolactin in man.

Authors:  A G Frantz; D L Kleinberg; G L Noel
Journal:  Recent Prog Horm Res       Date:  1972

4.  An antilactogenic effect of pyridoxine.

Authors:  M D Foukas
Journal:  J Obstet Gynaecol Br Commonw       Date:  1973-08

5.  Behavioral effects of L-dopa in schizophrenic patients.

Authors:  B Angrist; G Sathananthan; S Gershon
Journal:  Psychopharmacologia       Date:  1973-07-04

6.  Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.

Authors:  P S Papavasiliou; G C Cotzias; S E Düby; A J Steck; C Fehling; M A Bell
Journal:  N Engl J Med       Date:  1972-01-06       Impact factor: 91.245

7.  Proceedings: Effect of intravenous d-amphetamine, 1-amphetamine and methylphenidate in schizophrenics.

Authors:  D S Janowski; J M Davis; M K El-Yousef
Journal:  Psychopharmacol Bull       Date:  1974-07

8.  Effect of pyridoxine on human hypophyseal trophic hormone release: a possible stimulation of hypothalamic dopaminergic pathway.

Authors:  G Delitala; A Masala; S Alagna; L Devilla
Journal:  J Clin Endocrinol Metab       Date:  1976-03       Impact factor: 5.958

9.  Suppression of pimozide-induced prolactin secretion by piridoxine (vitamin B6).

Authors:  G Delitala; A Masala; S Alagna
Journal:  Biomedicine       Date:  1977-07

10.  Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.

Authors:  G Tolis; R Laliberté; H Guyda; F Naftolin
Journal:  J Clin Endocrinol Metab       Date:  1977-06       Impact factor: 5.958

View more
  1 in total

1.  Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis.

Authors:  Zhe Lu; Yaoyao Sun; Yuyanan Zhang; Yu Chen; Liangkun Guo; Yundan Liao; Zhewei Kang; Xiaoyang Feng; Weihua Yue
Journal:  Transl Psychiatry       Date:  2022-07-05       Impact factor: 7.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.